Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/PHARMABCINE-INC-64310825/news/PharmAbcine-Inc-gibt-bekannt-dass-der-erste-Patient-in-die-klinische-Phase-Ii-Studie-zur-Behandlun-37430874/?utm_source=whatsapp&utm_medium=social&utm_campaign=share